Centiva Capital »

Myriad Genetics shares owned by Centiva Capital

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $271k 14k 19.14
2023-03-31 $242k 10k 23.23

More positions owned by Centiva Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr National Mun Etf (MUB)
Ishares Tr 1 3 Yr Treas Bd Call Option (SHY)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
stock
Simon Property Call Option (SPG)
Agnc Invt Corp Com reit Call Option (AGNC)
Advanced Micro Devices (AMD)
Citigroup Com New Call Option (C)

View all positions for Centiva Capital

Top funds holding Myriad Genetics

Vanguard Group
Wellington Management Company
Glenview Captal Management
Earnest Partners
Millennium Management
Bank of America Corporation
Dimensional Fund Advisors
Artisan Partners Limited Partnership
Sei Investments
D. E. Shaw & Co
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management
Bank of New York Mellon
Principal Financial Group

View all funds holding Myriad Genetics